220 related articles for article (PubMed ID: 37824028)
1. Adverse Drug Reactions to Opioids: A Study in a National Pharmacovigilance Database.
Gustafsson M; Matos C; Joaquim J; Scholl J; van Hunsel F
Drug Saf; 2023 Nov; 46(11):1133-1148. PubMed ID: 37824028
[TBL] [Abstract][Full Text] [Related]
2. Safety concerns reported by consumers, manufacturers and healthcare professionals: A detailed evaluation of opioid-related adverse drug reactions in the FDA database over 15 years.
Andreaggi CA; Novak EA; Mirabile ME; Sampathkumar S; Gray MP; He M; Kane-Gill SL
Pharmacoepidemiol Drug Saf; 2020 Dec; 29(12):1627-1635. PubMed ID: 32851782
[TBL] [Abstract][Full Text] [Related]
3. Pharmacovigilance Signals of the Opioid Epidemic over 10 Years: Data Mining Methods in the Analysis of Pharmacovigilance Datasets Collecting Adverse Drug Reactions (ADRs) Reported to EudraVigilance (EV) and the FDA Adverse Event Reporting System (FAERS).
Chiappini S; Vickers-Smith R; Guirguis A; Corkery JM; Martinotti G; Harris DR; Schifano F
Pharmaceuticals (Basel); 2022 May; 15(6):. PubMed ID: 35745593
[TBL] [Abstract][Full Text] [Related]
4. Adverse drug reaction monitoring: support for pharmacovigilance at a tertiary care hospital in Northern Brazil.
Lobo MG; Pinheiro SM; Castro JG; Momenté VG; Pranchevicius MC
BMC Pharmacol Toxicol; 2013 Jan; 14():5. PubMed ID: 23298396
[TBL] [Abstract][Full Text] [Related]
5. Trends in adverse drug reactions related to oral weak opioid analgesics in therapeutic use in adults: A 10-year French vigilances retrospective study.
Caré W; Pinel S; Dufayet L; Langrand J; Micallef J; Vodovar D
Fundam Clin Pharmacol; 2023 Dec; 37(6):1205-1217. PubMed ID: 37400273
[TBL] [Abstract][Full Text] [Related]
6. Reporting rate of adverse drug reactions to the French pharmacovigilance system with three step 2 analgesic drugs: dextropropoxyphene, tramadol and codeine (in combination with paracetamol).
Tavassoli N; Lapeyre-Mestre M; Sommet A; Montastruc JL;
Br J Clin Pharmacol; 2009 Sep; 68(3):422-6. PubMed ID: 19740400
[TBL] [Abstract][Full Text] [Related]
7. [Side effects of tramadol: 12 years of experience in the Netherlands].
Kabel JS; van Puijenbroek EP
Ned Tijdschr Geneeskd; 2005 Apr; 149(14):754-7. PubMed ID: 15835626
[TBL] [Abstract][Full Text] [Related]
8. Drug-Induced Sexual Dysfunction: An Analysis of Reports to a National Pharmacovigilance Database.
Valeiro C; Matos C; Scholl J; van Hunsel F
Drug Saf; 2022 Jun; 45(6):639-650. PubMed ID: 35386045
[TBL] [Abstract][Full Text] [Related]
9. New guideline for tramadol usage following adverse drug reactions reported to the Iranian Pharmacovigilance Center.
Gholami K; Shalviri G; Zarbakhsh A; Daryabari N; Yousefian S
Pharmacoepidemiol Drug Saf; 2007 Feb; 16(2):229-37. PubMed ID: 17063533
[TBL] [Abstract][Full Text] [Related]
10. Using structural topic modelling to reveal patterns in reports on opioid drugs in a pharmacovigilance database.
Lösch L; Brown P; van Hunsel F
Pharmacoepidemiol Drug Saf; 2022 Sep; 31(9):1003-1006. PubMed ID: 35751621
[TBL] [Abstract][Full Text] [Related]
11. Adverse drug reactions of non-opioid and opioid analgesics reported to Croatian national authority from 2007 to 2014.
Sunara P; Krnic D; Puljak L
Acta Med Acad; 2017 Nov; 46(2):94-104. PubMed ID: 29338273
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.
Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC
Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758
[TBL] [Abstract][Full Text] [Related]
13. Psychiatric adverse drug reactions in the paediatric population.
Ekhart C; Vries T; Hunsel FV
Arch Dis Child; 2020 Aug; 105(8):749-755. PubMed ID: 32060030
[TBL] [Abstract][Full Text] [Related]
14. [Tolerance and safety of tramadol use. Results of international studies and data from drug surveillance].
Cossmann M; Kohnen C; Langford R; McCartney C
Drugs; 1997; 53 Suppl 2():50-62. PubMed ID: 9190325
[TBL] [Abstract][Full Text] [Related]
15. Adverse Drug Reactions in Children: Comparison of Reports Collected in a Pharmacovigilance Project Versus Spontaneously Collected ADR Reports.
Leitzen S; Dubrall D; Toni I; Stingl J; Christ P; Köberle U; Schmid M; Neubert A; Sachs B
Paediatr Drugs; 2023 Mar; 25(2):203-215. PubMed ID: 36369590
[TBL] [Abstract][Full Text] [Related]
16. Comparison between paediatric and adult suspected adverse drug reactions reported to the European medicines agency: implications for pharmacovigilance.
Blake KV; Zaccaria C; Domergue F; La Mache E; Saint-Raymond A; Hidalgo-Simon A
Paediatr Drugs; 2014 Aug; 16(4):309-19. PubMed ID: 24898717
[TBL] [Abstract][Full Text] [Related]
17. Opioid analgesics are the leading cause of adverse drug reactions in the obstetric population in South Korea.
Choi SK; Kim YH; Kim SM; Wie JH; Lee DG; Kwon JY; Song JH; Lee SJ; Park IY
Medicine (Baltimore); 2019 May; 98(21):e15756. PubMed ID: 31124960
[TBL] [Abstract][Full Text] [Related]
18. Safety analysis of therapeutic drugs for breast cancer patients and construction of a predictive model for serious adverse drug reactions.
Lin S; Lei S; Liu W; Zhu X; Ren B; Feng B
Eur J Clin Pharmacol; 2024 Feb; 80(2):249-259. PubMed ID: 38099939
[TBL] [Abstract][Full Text] [Related]
19. Health benefits of an adverse events reporting system for chronic pain patients using long-term opioids.
Planelles B; Margarit C; Ajo R; Sastre Y; Muriel J; Inda MD; Esteban MD; Peiró AM
Acta Anaesthesiol Scand; 2019 Feb; 63(2):248-258. PubMed ID: 30109708
[TBL] [Abstract][Full Text] [Related]
20. Analysis of Reporting Adverse Drug Reactions in Paediatric Patients in a University Hospital in the Netherlands.
Dittrich ATM; Draaisma JMT; van Puijenbroek EP; Loo DMWMT
Paediatr Drugs; 2020 Aug; 22(4):425-432. PubMed ID: 32557243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
